Zhang Tao, Zheng Yi, Zhao Dongyang, Yan Jingmin, Sun Chongliang, Zhou Yifa, Tai Guihua
Jilin Province Key Laboratory for Chemistry and Biology of Natural Drugs in Changbai Mountain, School of Life Sciences, Northeast Normal University, Changchun 130024, PR China.
Jilin Province Key Laboratory for Chemistry and Biology of Natural Drugs in Changbai Mountain, School of Life Sciences, Northeast Normal University, Changchun 130024, PR China.
Int J Biol Macromol. 2016 Oct;91:994-1001. doi: 10.1016/j.ijbiomac.2016.06.058. Epub 2016 Jun 18.
Although several approaches have been used to evaluate binding of carbohydrates to lectins, results are not always comparable, especially with larger polysaccharides. Here, we quantitatively assessed and compared binding of pectin-derived polysaccharides to galectin-3 (Gal-3) using five methods: surface plasmon resonance (SPR), bio-layer interferometry (BLI), fluorescence polarization (FP), competitive fluorescence-linked immunosorbance (cFLISA), and the well-known cell-based hemagglutination assay (G3H). Our studies revealed that whereas Gal-3-pectin binding parameters determined by SPR and BLI were comparable and correlated with inhibitory potencies from the G3H assay, results using FP and cFLISA assays were highly variable and depended greatly on the probe and mass of the polysaccharide. In the cFLISA assay, for example, pectins showed no inhibition when using the DTAF-labeled asialofetuin probe, but did when using a DTAF-labeled pectin probe. And the FP approach with the DTAF-lactose probe did not work on polysaccharides and large galactan chains, although it did work well with smaller galactans. Nevertheless, even though results derived from all of these methods are in general agreement, derived KD, IC50, and MIC values do differ. Our results reflect the variability using various techniques and therefore will be useful to investigators who are developing pectin-derived Gal-3 antagonists as anti-cancer agents.
尽管已经采用了多种方法来评估碳水化合物与凝集素的结合,但结果并不总是具有可比性,尤其是对于较大的多糖。在这里,我们使用五种方法定量评估并比较了果胶衍生的多糖与半乳糖凝集素-3(Gal-3)的结合:表面等离子体共振(SPR)、生物层干涉术(BLI)、荧光偏振(FP)、竞争性荧光联免疫吸附测定(cFLISA)以及著名的基于细胞的血细胞凝集试验(G3H)。我们的研究表明,虽然通过SPR和BLI测定的Gal-3与果胶的结合参数具有可比性,并且与G3H试验的抑制效力相关,但使用FP和cFLISA试验得到的结果高度可变,并且在很大程度上取决于多糖的探针和质量。例如,在cFLISA试验中,当使用DTAF标记的去唾液酸胎球蛋白探针时,果胶没有显示出抑制作用,但使用DTAF标记的果胶探针时则有抑制作用。并且使用DTAF-乳糖探针的FP方法对多糖和大的半乳聚糖链不起作用,尽管它对较小的半乳聚糖效果良好。然而,尽管所有这些方法得到的结果总体上是一致的,但得到的KD、IC50和MIC值确实存在差异。我们的结果反映了使用各种技术时的变异性,因此对于正在开发果胶衍生的Gal-3拮抗剂作为抗癌药物的研究人员将是有用的。